Rare success for Alzheimer's research unlocks hope for future therapies
Source: Reuters
CHICAGO, Nov 29 (Reuters) - The first big breakthrough in 30 years of Alzheimer’s research is providing momentum for clinical trials of “cocktail” treatments targeting the two hallmark proteins associated with the mind-robbing disease, according to interviews with researchers and pharmaceutical executives.Drugmakers Eisai Co Ltd (4523.T) and Biogen (BIIB.O) reported in September that their therapy lecanemab could…
This is aggregated or syndicated coverage. Reporting and media belong to the original publisher.
Read the original source at Reuters